Rgenta Therapeutics

Who: GSK and Relation Therapeutics What: The UK major has linked up with fellow London-based group Relation on two “multi-program strategic collaborations” which will focus on the identification an

The end of each year brings a surge in venture capital funding announcements as biopharmaceutical companies and investors seek to close as many deals as possible before everyone takes off for the Dece

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Seagen, RemeGen Partner Outside Asia, E

Venture capital firms focused on biopharmaceutical companies raised $810m across two new funds during the past two weeks, including $550m for venBio and Ysios Capital’s recently closed €216m ($260m) f